Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Topoisomerases in human disease.

R J Epstein1

  • 1University Department of Clinical Oncology and Radiotherapeutics, Addenbrooke's Hospital, Cambridge.

Lancet (London, England)
|March 5, 1988
PubMed
Summary

Topoisomerases, enzymes that modify DNA, are crucial in medicine. They are targets for drugs and implicated in genetic disorders, with strategies for their clinical manipulation discussed.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A randomised phase II trial of three dosing regimens of radium-223 in patients with bone metastatic castration-resistant prostate cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Resolution of paraneoplastic immune thrombocytopenia following everolimus treatment for metastatic renal cell carcinoma.

Internal medicine journal·2015
Same author

Intermittent androgen deprivation is a rational standard-of-care treatment for all stages of progressive prostate cancer: results from a systematic review and meta-analysis.

Prostate cancer and prostatic diseases·2014
Same author

Anticancer activity of combination targeted therapy using cetuximab plus vemurafenib for refractory BRAF (V600E)-mutant metastatic colorectal carcinoma.

Current oncology (Toronto, Ont.)·2014
Same author

Has discovery-based cancer research been a bust?

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2013
Same author

Death in The New York Times: the price of fame is a faster flame.

QJM : monthly journal of the Association of Physicians·2013

Area of Science:

  • Biochemistry and Molecular Biology
  • Enzymology
  • Clinical Medicine

Background:

  • Topoisomerases are essential DNA-modifying enzymes.
  • Their clinical significance is rapidly growing.
  • They play roles in antibiotic, antitumour drug development, and genetic disorders.

Purpose of the Study:

  • To discuss the clinical importance of topoisomerases.
  • To review strategies for manipulating topoisomerases in clinical settings.
  • To highlight the role of topoisomerases in disease pathogenesis and treatment.

Main Methods:

  • Literature review of topoisomerase functions and clinical applications.
  • Analysis of topoisomerases as therapeutic targets.
  • Discussion of genetic disorder associations.

Main Results:

  • Topoisomerases are validated targets for antibiotics and antitumour agents.
  • Clinical manipulation strategies for topoisomerases are actively being developed.
  • Topoisomerases are implicated in the pathogenesis of various genetic disorders.

Conclusions:

  • Topoisomerases represent a critical class of enzymes with expanding clinical relevance.
  • Targeting topoisomerases offers promising therapeutic avenues for infections, cancer, and genetic diseases.
  • Further research into topoisomerase manipulation is warranted for clinical advancement.

Related Experiment Videos